TITLE

Spac Strikes Juicy Deal

AUTHOR(S)
O'Connor, Colleen Marie
PUB. DATE
March 2006
SOURCE
Investment Dealers' Digest;3/20/2006, Vol. 72 Issue 11, p12
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the sale of the concept restaurant franchise Jamba Juice to a special purpose acquisition corporation (Spac). The sale underscores how selling out to a Spac can be an attractive alternative for small and midsize private companies. Many expect Spacs to be more competitive with private equity and initial public offerings (IPOs) in 2006 when it comes to financing growth companies or providing exits for venture capital investors.
ACCESSION #
20232750

 

Related Articles

  • The Liquidity Landscape. Mix, Darrick; Rubin, Chad // Mergers & Acquisitions: The Dealermaker's Journal;Feb2012, Vol. 47 Issue 2, p54 

    In this article the authors discuss exit transactions for middle-market companies. According to the authors, the most common exit strategies are third-party sales to strategic or financial buyers; and initial public offerings (IPOs) and dividend recapitalizations are less common exit strategies....

  • Private equity pros: No Bain, no gain? Steve Rockwell.  // Nation's Restaurant News;6/25/2012, Vol. 46 Issue 13, p22 

    The article discusses the role of private equity in the restaurant industry. With the growing public equity market for restaurant financings, private equity firms are lining up to take advantage of the scenario. Ignite Restaurant Group floated a very successful initial public offering (IPO) in...

  • Jamba Juice/Juice Club.  // Restaurant Business;07/15/2000, Vol. 99 Issue 14, p30 

    Focuses on Jamba Juice/Juice Club, a chain restaurant based in San Francisco, California. Annual sales since 1995; Expansion moves; Opening of stores in Illinois, Massachusetts and Washington, D.C.; Venture into the lunch business; Product offerings.

  • Popeyes chicken & biscuits: Louisiana legends stirs up QSR.  // Nation's Restaurant News;05/24/99, Vol. 33 Issue 21, p170 

    Features restaurant company Jamba Juice, winner of the `National Restaurant News' magazine's 1999 MenuMasters Award for Best Healthy Choice Menu Selection. Company background; Company's introduction of its Jambola breads in the year 1998.

  • Jamba Juice. Rowe, Megan // Restaurant Business;7/1/2001, Vol. 100 Issue 13, p42 

    Focuses on the United States restaurant chain called Jamba Juice. Chief executive officer Paul Clayton's description of the uses of Jamba; Number of locations; Sales in 2000; Founding of the company as Juice Club in 1990 by Kirk Perron; Offer of a health-conscious alternative fast food;...

  • INVESTORS SHY AWAY FROM IPOS. Iskyan, Kim // Global Finance;Mar2007, Vol. 21 Issue 3, p12 

    The article focuses on the impact of the initial public offerings (IPOs) towards the investors in Russia. Norilsk Nickel chief executive officer (CEO) Mikhail Prokhorov will sell his stake in the world's largest platinum and palladium producers to partner Vladimir Potanin. President Vladimir...

  • Against the Wind. Tarbous, Ken // Mergers & Acquisitions Report;6/28/2010, Vol. 23 Issue 26, p1 

    The article examines the state of the initial public offering (IPO) market. IPO issuance in recent months have dramatically slowed down due to concerns about the sovereign debt crisis in Europe and according to Ipreo Capital Markets Analytics, only three IPOs amounting to 210 million U.S....

  • Why the IPO Offers a Rocky Exit for Financial Buyers. Sikora, Martin // Mergers & Acquisitions: The Dealermaker's Journal;Oct2004, Vol. 39 Issue 10, p14 

    Discusses the advantages and disadvantages of initial public offerings (IPO) for private equity firms. Comparison between the complete sale of a company and an IPO; Information on several portfolio companies that were acquired before going public, as of September 2004; Information on private...

  • Akzo plays down Organon sale. Ovrebekk, Hilde; Davis, Nigel; Chang, Joseph // ICIS Chemical Business Americas;1/8/2007, Vol. 271 Issue 1, p6 

    The article reports that Akzo Nobel denied its plan to sell its Organon drugs business to private equity instead of going ahead with its initial public offering (IPO) plan. The sale of Organon human health care and the Intervet animal health businesses to private investors continue to eye a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics